Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jun 15:13:399-404.
doi: 10.2147/CCID.S251356. eCollection 2020.

The Correlation of Semmes-Weinstein Monofilament Test with the Level of P-75 Neurotrophin as Marker of Nerve Damage in Leprosy

Affiliations

The Correlation of Semmes-Weinstein Monofilament Test with the Level of P-75 Neurotrophin as Marker of Nerve Damage in Leprosy

Dhelya Widasmara et al. Clin Cosmet Investig Dermatol. .

Abstract

Introduction: Leprosy is a chronic infectious disease caused by Mycobacterium leprae that causes damage to the peripheral nerve, particularly Schwann cells. Treatment is useful only to kill bacteria but not to recover peripheral nerve damage. However, early detection of peripheral nerve damage is necessary. We examine P-75 neurotrophin (P75NTR) as an indicator of peripheral nerve damage in leprosy with the Semmes-Weinstein monofilament (SWM) test as the comparison.

Methods: This study uses a quantitative analytic observational study approach with cross-sectional design, conducted at Kediri Leprosy Hospital, Malang, East Java, Indonesia. All leprosy patients had a clinical examination and bacterial index to classify leprosy and then the SWM test to examine the presence of neuropathy in the palms and feet. P75NTR examination uses venous blood samples. An independent t-test was used to compare the SWM and P75NTR scores based on the type of leprosy, and then the Spearman correlation test was used to determine the correlation between SWM scores and P75NTR levels.

Results: In this study, SWM scores on the soles of the foot and palms and the P75NTR levels were higher in the PB group compared with MB (p<0.05). Also, a significant positive correlation was found between P75NTR and the SWM scores on the palms of the hand (r=0.864; p=0.000) and the soles of the foot (r=0.864; p=0.000).

Conclusion: There is a strong positive correlation between P75NTR levels and SWM scores, so P75NTR levels are very likely to be a marker of neuropathy in leprosy, but further studies are still needed to examine the specific role of these biomarkers.

Keywords: P-75 neurotrophin; Semmes–Weinstein monofilament test; leprosy.

PubMed Disclaimer

Conflict of interest statement

The authors declare there is no conflict of interest regarding publication of current article.

Figures

Figure 1
Figure 1
Monofilament test points for examination.
Figure 2
Figure 2
Average SWM score on leprosy patients’ palms between MB and PB types of leprosy.
Figure 3
Figure 3
Average SWM score on leprosy patients’ feet between MB and PB types of leprosy.
Figure 4
Figure 4
Comparison of P75NTR levels between MB and PB leprosy patients.
Figure 5
Figure 5
Correlation between P75NTR levels with SWM scores on the palms.
Figure 6
Figure 6
Correlation between P75NTR levels with SWM scores on the feet.

References

    1. Anand P. Neurotrophic factors and their receptors in human sensory neuropathies. Prog Brain Res. 2004;146:477–492. - PubMed
    1. Dechant G, Barde Y-A. The neurotrophin receptor p75NTR: novel functions and implications for diseases of the nervous system. Nat Neurosci. 2002;5(11):1131–1136. doi:10.1038/nn1102-1131 - DOI - PubMed
    1. WHO. Neglected tropical disease. Geneve: WHO Available from: https://www.who.int/neglected_diseases/diseases/en/. Accessed May15, 2020.
    1. Kusumaningrum N, Purnamawati S, Winarni DRA, Soebono H. Lepromatous leprosy mimicking systemic lupus erythematosus: a case report. Med J Indones. 2019;28(1):77–81. doi:10.13181/mji.v28i1.1793 - DOI
    1. Facer P, Mann D, Mathur R, et al. Do nerve growth factor-related mechanisms contribute to loss of cutaneous nociception in leprosy? Pain. 2000;85:231–238. doi:10.1016/S0304-3959(99)00273-0 - DOI - PubMed